Login / Signup

A systematic review of the economic value proposition for commercially available nonsurgical weight-loss interventions.

Eric Andrew FinkelsteinParth A ChodavadiaKiersten Strombotne
Published in: Obesity (Silver Spring, Md.) (2023)
Evidence of cost-effectiveness for commercially available, evidence-based, nonsurgical weight-loss interventions is mixed. There is no evidence for cost-saving weight-loss medications and only weak evidence for behavioral and weight-loss interventions. Results provide a call to action to generate more robust evidence of the economic value proposition for these interventions.
Keyphrases
  • weight loss
  • bariatric surgery
  • roux en y gastric bypass
  • gastric bypass
  • physical activity
  • glycemic control
  • body mass index
  • obese patients
  • insulin resistance
  • weight gain